Caitlin Raymond: Anticoagulation and TPE: More Nuanced Than You Think!
Caitlin Raymond, a board-certified Clinical Pathologist and current Transfusion Medicine Fellow at the National Institutes of Health, shared on LinkedIn:
”Anticoagulation and TPE: More Nuanced Than You Think
When you see “anticoagulated patient” and “therapeutic plasma exchange (TPE)” in the same sentence, the reflex is clear: they’re going to bleed.
But that’s not always the case.
Over the last few years on service, I’ve learned that the reality is more complicated — and more interesting.
TPE doesn’t interact with all anticoagulants in the same way.
Some are cleared, some aren’t.
Some look scary on paper (hello, post-exchange INR bumps) but don’t consistently translate into bleeding at the bedside.
And antiplatelet agents? Not irrelevant — but not the whole story either.
In this new piece, I walk through:
- Which anticoagulants are actually removed by TPE
- When (and how) to adjust dosing
- How citrate anticoagulation fits into the picture
- What the reversal options look like
- Why short courses are usually safe — and when bleeding risk does rise
The key takeaway: “anticoagulated” doesn’t automatically mean “unsafe.”
The art is knowing which drug, how often, and what else is going on with the patient.
If you’re running TPE, or just want a refresher on how meds and machines collide, I’d love for you to give it a read.”
Read the full post here.
Find more on coagulation disorders featured in Hemostasis Today.
-
Feb 23, 2026, 15:16Amira Khater: Key Updates on Pulmonary Embolism Management from AHA and ACC Guidelines
-
Feb 23, 2026, 14:45Stacey McGeown: Rare Disease Awareness Day at QUB Marks the Start of Rare Disease Month
-
Feb 23, 2026, 13:53Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 1
-
Feb 23, 2026, 13:02Deepak Yadav: What 2025 Evidence Tells Us About Stroke Care
-
Feb 23, 2026, 12:55Radoslaw Kaczmarek: Will AAV Gene Therapy for Hemophilia Trigger Tumorigenesis?
-
Feb 23, 2026, 12:46Heghine Khachatryan: More Granular Risk Stratification Framework for PE from The New 2026 AHA/ACC Guideline
-
Feb 23, 2026, 12:37Reza Shojaei: EU’s Critical Medicines Act and Plasma Resilience
-
Feb 23, 2026, 12:32Anirban Sen Gupta: Emily Mihalko Highlights PlateChek at MTEC
-
Feb 23, 2026, 12:25Ryan Williams: Excellent Highlights on The Heterogeneity of PRP Preparation